论文部分内容阅读
目的探讨噻托溴铵粉雾剂治疗慢性阻塞性肺气肿的临床疗效。方法对照组60例患者均给予爱全乐(异丙托溴铵气雾剂)雾化治疗;研究组60例患者均给予名思力华(噻托溴铵粉雾剂)雾化治疗。结果研究组治疗后FEV1和FEV1/FVC值明显高于对照组,且研究组FEV1改善率明显优于对照组(P﹤0.05)。研究组治疗后生活质量评分明显高于对照组,数据经统计学比较差异有统计学意义(P﹤0.05)。两组并发症发生率经统计学比较差异无统计学意义(P﹥0.05)。结论噻托溴铵粉雾剂治疗慢性阻塞性肺气肿具有较好的临床疗效和安全性,能够有效改善和提高患者的生活质量。
Objective To investigate the clinical efficacy of tiotropium bromide aerosol in the treatment of chronic obstructive pulmonary emphysema. Methods A total of 60 patients in the control group were treated with Atrazine (ipratropium bromide aerosol) atomization therapy. All 60 patients in the study group were given siligen (Tiotropium bromide powder aerosol) atomization therapy. Results The FEV1 and FEV1 / FVC values in the study group were significantly higher than those in the control group. The improvement rate of FEV1 in the study group was significantly better than that in the control group (P <0.05). The quality of life of the study group after treatment was significantly higher than the control group, the data by the statistical difference was statistically significant (P <0.05). There was no significant difference in the incidence of complications between the two groups (P> 0.05). Conclusion Tiotropium bromide powder aerosol treatment of chronic obstructive pulmonary disease has a good clinical efficacy and safety, can effectively improve and improve the quality of life of patients.